This was firstly established in AD patient brains, where tau pathology was found to propagate from the entorhinal cortex through the hippocampus and into the limbic and associated cortexes, which correlates with the clinical cognitive status of the patient [104]. The gene discussed is MAPT; the disease is Alzheimer disease.